Periodontal status of adult patients treated with fixed buccal appliances and removable aligners over one year of active orthodontic therapy.
OBJECTIVE
To compare the periodontal status of adults treated with fixed buccal orthodontic appliances vs removable orthodontic aligners over 1 year of active therapy.


METHODS
The study population consisted of 42 subjects; 22 treated with fixed buccal orthodontic appliances and 20 treated with removable aligners. Clinical indices recorded included: plaque index (PI), gingival index (GI), bleeding on probing (BOP), and probing pocket depth (PPD). Plaque samples were assessed for hydrolysis of N-benzoyl-DL-arginine-naphthylamide (BANA test). Indices and BANA scores were recorded before treatment and at 6 weeks, 6 months, and 12 months after initiation of orthodontic therapy.


RESULTS
After 6 weeks, only mean PPD was greater in the fixed buccal orthodontic appliance group. However, after 6 months, the fixed buccal orthodontic appliance group had significantly greater mean PI, PPD, and GI scores and was 5.739 times more likely to have a higher BANA score. After 12 months, the fixed buccal orthodontic appliance group continued to have greater mean PI, GI, and PPD, while a trend was noted for higher BANA scores and BOP.


CONCLUSIONS
These results suggest treatment with fixed buccal orthodontic appliances is associated with decreased periodontal status and increased levels of periodontopathic bacteria when compared to treatment with removable aligners over the 12-month study duration.
Marzieh
M
Karkhanechi
Denise
D
Chow
Jennifer
J
Sipkin
David
D
Sherman
Robert J
RJ
Boylan
Robert G
RG
Norman
Ronald G
RG
Craig
George J
GJ
Cisneros
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001587:Benzoylarginine-2-Naphthylamide; D003773:Dental Plaque / Q000209:etiology* / Q000382:microbiology; D003774:Dental Plaque Index; D005260:Female; D005881:Gingiva / Q000382:microbiology*; D006801:Humans; D008297:Male; D016382:Orthodontic Appliance Design; D009967:Orthodontic Appliances / Q000009:adverse effects*; D010512:Periodontal Index; D011446:Prospective Studies
D001587:Benzoylarginine-2-Naphthylamide